Former OtisMed CEO gets 2 years in prison in knee device scandal — 5 key notes

Laura Dyrda -   Print  |

Former OtisMed CEO Charli Chi will go to prison for his roll in marketing and distributing knee replacement tools that weren't cleared by the FDA, according to News Works.

Here are five things to know:


1. Mr. Chi pled guilty to distributing surgical tools for knee replacements using an FDA-rejected marking plan.


2. OtisMed has since been purchased by Stryker. The company was fined more than $80 million for criminal and civil charges.


3. Mr. Chi was sentenced to 24 months in prison.


4. Stryker wasn't aware of OtisMed's illegal actions when purchasing the company, but they did cooperate with the FDA investigation.


5. OtisMed sold cutting guides before clearing claims about the device, and the FDA later rejected those claims.


More articles on orthopedic devices:
Zimmer, Medtronic, Amendia & more—27 key notes
Tyber Medical launches lateral retractor system
Simponi receives CE mark

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers